Equity
Total Liabilities & Equity
Vertex Pharmaceuticals Total Liabilities & Equity increased by 3.3% to $26.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from $22.88B to $26.48B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 16.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Changes in this total reflect the overall scale and growth of the company's balance sheet.
Detailed definition
This represents the total funding sources of the company, comprising both debt obligations and shareholder equity. By ac...
Peer comparison
Standard balance sheet identity used to assess the total size of the company's financial footprint.
Metric ID:
total_liabilities_and_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.22B | $12.62B | $13.43B | $14.26B | $15.58B | $16.71B | $18.15B | $18.97B | $20.35B | $21.73B | $22.73B | $23.92B | $20.13B | $22.24B | $22.53B | $22.88B | $24.04B | $24.86B | $25.64B | $26.48B |
| QoQ Change | — | +3.2% | +6.4% | +6.1% | +9.3% | +7.2% | +8.6% | +4.5% | +7.2% | +6.8% | +4.6% | +5.2% | -15.8% | +10.5% | +1.3% | +1.5% | +5.1% | +3.4% | +3.1% | +3.3% |
| YoY Change | — | — | — | — | +27.5% | +32.4% | +35.1% | +33.1% | +30.6% | +30.0% | +25.2% | +26.1% | -1.1% | +2.4% | -0.9% | -4.3% | +19.4% | +11.8% | +13.8% | +15.8% |
Range$12.22B – $26.48B
CAGR+17.7%
Avg YoY Growth+18.6%
Median YoY Growth+22.3%
Current Streak7 quarters growth
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's total liabilities & equity?
- Vertex Pharmaceuticals (VRTX) reported total liabilities & equity of $26.48B in Q1 2026.
- How has Vertex Pharmaceuticals's total liabilities & equity changed year-over-year?
- Vertex Pharmaceuticals's total liabilities & equity increased by 15.8% year-over-year, from $22.88B to $26.48B.
- What is the long-term trend for Vertex Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's total liabilities & equity has grown at a 16.9% compound annual growth rate (CAGR), from $11.75B to $25.64B.
- What does total liabilities & equity mean?
- The sum of all company debts and shareholder investments, which must equal total assets.